Cheryl E. G. Leyns

2.7k total citations
13 papers, 1.5k citations indexed

About

Cheryl E. G. Leyns is a scholar working on Neurology, Physiology and Immunology. According to data from OpenAlex, Cheryl E. G. Leyns has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Physiology and 5 papers in Immunology. Recurrent topics in Cheryl E. G. Leyns's work include Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Alzheimer's disease research and treatments (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Cheryl E. G. Leyns is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Alzheimer's disease research and treatments (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Cheryl E. G. Leyns collaborates with scholars based in United States, Canada and Greece. Cheryl E. G. Leyns's co-authors include David M. Holtzman, Maud Gratuze, Marco Colonna, Jason D. Ulrich, Lauren J. Koscal, Javier Remolina Serrano, Grace O. Robinson, Floy R. Stewart, Elise Anderson and Albert A. Davis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Cheryl E. G. Leyns

13 papers receiving 1.5k citations

Peers

Cheryl E. G. Leyns
Javier Remolina Serrano United States
Christophe Verbeeck United States
Kelly R. Miller United States
Nicholas H. Varvel United States
Elizabeth Allison United States
Guixiang Xu United States
Juan Piña-Crespo United States
Angie C.A. Chiang United States
Frédérique Bard United States
Rebecca Radde Germany
Javier Remolina Serrano United States
Cheryl E. G. Leyns
Citations per year, relative to Cheryl E. G. Leyns Cheryl E. G. Leyns (= 1×) peers Javier Remolina Serrano

Countries citing papers authored by Cheryl E. G. Leyns

Since Specialization
Citations

This map shows the geographic impact of Cheryl E. G. Leyns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl E. G. Leyns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl E. G. Leyns more than expected).

Fields of papers citing papers by Cheryl E. G. Leyns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl E. G. Leyns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl E. G. Leyns. The network helps show where Cheryl E. G. Leyns may publish in the future.

Co-authorship network of co-authors of Cheryl E. G. Leyns

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl E. G. Leyns. A scholar is included among the top collaborators of Cheryl E. G. Leyns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl E. G. Leyns. Cheryl E. G. Leyns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Brynildsen, Julia K., Cheryl E. G. Leyns, Lakshmi Changolkar, et al.. (2024). LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression. Translational Neurodegeneration. 13(1). 13–13. 7 indexed citations
2.
Leyns, Cheryl E. G., Alice Prigent, Lihang Yao, et al.. (2023). Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease. npj Parkinson s Disease. 9(1). 74–74. 18 indexed citations
3.
Bardehle, Sophia, Choya Yoon, Niyanta Kumar, et al.. (2023). Microglial roles in Alzheimer's disease: An agent‐based model to elucidate microglial spatiotemporal response to beta‐amyloid. CPT Pharmacometrics & Systems Pharmacology. 13(3). 449–463. 4 indexed citations
4.
Gratuze, Maud, Cheryl E. G. Leyns, Andrew D. Sauerbeck, et al.. (2020). Impact of TREM2R47H variant on tau pathology–induced gliosis and neurodegeneration. Journal of Clinical Investigation. 130(9). 4954–4968. 145 indexed citations
5.
Rideout, Hardy J., Marie‐Christine Chartier‐Harlin, Matthew Fell, et al.. (2020). The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease. Frontiers in Neuroscience. 14. 865–865. 31 indexed citations
6.
Leyns, Cheryl E. G., Maud Gratuze, Sneha Narasimhan, et al.. (2019). TREM2 function impedes tau seeding in neuritic plaques. Nature Neuroscience. 22(8). 1217–1222. 199 indexed citations
7.
Gallardo, Gilbert, Connie Wong, Kent Lin, et al.. (2019). Targeting tauopathy with engineered tau-degrading intrabodies. Molecular Neurodegeneration. 14(1). 38–38. 40 indexed citations
8.
Kling, Pamela J., et al.. (2018). Cord Blood Erythropoietin and Hepcidin Reflect Lower Newborn Iron Stores due to Maternal Obesity during Pregnancy. American Journal of Perinatology. 36(5). 511–516. 9 indexed citations
9.
Gratuze, Maud, Cheryl E. G. Leyns, & David M. Holtzman. (2018). New insights into the role of TREM2 in Alzheimer’s disease. Molecular Neurodegeneration. 13(1). 66–66. 327 indexed citations
10.
Davis, Albert A., Cheryl E. G. Leyns, & David M. Holtzman. (2018). Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Annual Review of Cell and Developmental Biology. 34(1). 545–568. 98 indexed citations
11.
Ising, Christina, Gilbert Gallardo, Cheryl E. G. Leyns, et al.. (2017). AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy. The Journal of Experimental Medicine. 214(5). 1227–1238. 42 indexed citations
12.
Leyns, Cheryl E. G. & David M. Holtzman. (2017). Glial contributions to neurodegeneration in tauopathies. Molecular Neurodegeneration. 12(1). 50–50. 286 indexed citations
13.
Leyns, Cheryl E. G., Jason D. Ulrich, Mary Beth Finn, et al.. (2017). TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proceedings of the National Academy of Sciences. 114(43). 11524–11529. 334 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier Remolina Serrano Breakdown of academic impact, for papers by Christophe Verbeeck Breakdown of academic impact, for papers by Kelly R. Miller Breakdown of academic impact, for papers by Nicholas H. Varvel Breakdown of academic impact, for papers by Elizabeth Allison Breakdown of academic impact, for papers by Guixiang Xu Breakdown of academic impact, for papers by Juan Piña-Crespo Breakdown of academic impact, for papers by Angie C.A. Chiang Breakdown of academic impact, for papers by Frédérique Bard Breakdown of academic impact, for papers by Rebecca Radde
Rankless by CCL
2026